Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

915098

	registered interest
	date	01/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to allocate funding to more efficient forms of radiotherapy technology; and if he will make a statement.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	148714
	answer	answer is ministerial correction date of answer 06/06/2018 answer text <p>Significant investments have been, and continue to be, made to improve both the efficiency of radiotherapy equipment and the range of more innovative radiotherapy treatments that are routinely available to patients:</p><p>- In October 2016, NHS England announced a £130 million fund to modernise radiotherapy across England, ensuring that older linear accelerators (LINACs - radiotherapy machines) are either upgraded or replaced. These upgraded/new machines will deliver both a wider range of innovative treatment techniques and are also significantly faster, enabling more patients to benefit from the latest technology regardless of where they live;</p><p>- NHS England has also committed £15 million over three years to evaluate the benefits of stereotactic ablative radiotherapy (SABR) in the treatment of a number of new clinical indications. SABR is an innovative radiotherapy technique that more precisely targets cancers with radiotherapy, reducing the damage to the surrounding tissues. A further £6 million was also committed by NHS England to support a number of Cancer Research UK sponsored SABR clinical trials. It is envisaged that the results of both the trials and the evaluation programme will enable more patients to routinely access SABR treatments;</p><p>- Following an investment of £23 million to improve access to Intensity Modulated Radiotherapy (IMRT), another more precise form of radiotherapy with fewer side effects, the National Health Service is now regularly exceeding access standards, meaning that more people are benefiting from this treatment. The percentage of radiotherapy patients who received IMRT increased from 10% (1,660) in April to June 2012 to 44% (8,865) in January to March 2017. The current access standard is 24%; and</p><p>- In 2012, the Government provided £250 million to build two proton beam therapy centres in England (at University College London Hospital and The Christie in Manchester), the first of which will become operational in autumn 2018.</p><p>No assessment has been made of the effect of national prices for radiotherapy treatment.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 148715 question first answered 06/06/2018 16:01:48 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

915099

	registered interest
	date	01/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the internal market tariff on the effectiveness of the NHS delivery of radiotherapy.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	148715
	answer	answer is ministerial correction date of answer 06/06/2018 answer text <p>Significant investments have been, and continue to be, made to improve both the efficiency of radiotherapy equipment and the range of more innovative radiotherapy treatments that are routinely available to patients:</p><p>- In October 2016, NHS England announced a £130 million fund to modernise radiotherapy across England, ensuring that older linear accelerators (LINACs - radiotherapy machines) are either upgraded or replaced. These upgraded/new machines will deliver both a wider range of innovative treatment techniques and are also significantly faster, enabling more patients to benefit from the latest technology regardless of where they live;</p><p>- NHS England has also committed £15 million over three years to evaluate the benefits of stereotactic ablative radiotherapy (SABR) in the treatment of a number of new clinical indications. SABR is an innovative radiotherapy technique that more precisely targets cancers with radiotherapy, reducing the damage to the surrounding tissues. A further £6 million was also committed by NHS England to support a number of Cancer Research UK sponsored SABR clinical trials. It is envisaged that the results of both the trials and the evaluation programme will enable more patients to routinely access SABR treatments;</p><p>- Following an investment of £23 million to improve access to Intensity Modulated Radiotherapy (IMRT), another more precise form of radiotherapy with fewer side effects, the National Health Service is now regularly exceeding access standards, meaning that more people are benefiting from this treatment. The percentage of radiotherapy patients who received IMRT increased from 10% (1,660) in April to June 2012 to 44% (8,865) in January to March 2017. The current access standard is 24%; and</p><p>- In 2012, the Government provided £250 million to build two proton beam therapy centres in England (at University College London Hospital and The Christie in Manchester), the first of which will become operational in autumn 2018.</p><p>No assessment has been made of the effect of national prices for radiotherapy treatment.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 148714 question first answered 06/06/2018 16:01:48 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

919198

	registered interest
	date	07/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of the £130 million allocated to modernise radiotherapy has been spent on new linac machines for newly commissioned satellite centres.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	151134
	answer	answer is ministerial correction date of answer 14/06/2018 answer text <p>The purpose of the £130 million modernisation fund was to upgrade or replace existing, older radiotherapy equipment. None of this funding was therefore spent on new equipment for newly commissioned satellite centres. Future funding decisions, including on new satellite centres, will be made after the fund ends in October 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/06/2018 10:56:11 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

968146

	registered interest
	date	05/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the performance of Clinical Commissioning Groups to improve access to advanced radiotherapy.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	170800
	answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>Clinical commissioning groups are not responsible for ensuring access to advanced radiotherapy techniques, such as Intensity Modulated Radiotherapy (IMRT). The commissioning of all radiotherapy in England is the responsibility of NHS England’s Specialised Commissioning team. Access to IMRT is monitored against a national average access standard of 25%, performance against this standard is consistently around 45%. From April 2019, Radiotherapy Networks, working in close partnership with Specialised Commissioners and Cancer Alliances, will play a key role in increasing access to both advanced and innovative radiotherapy, as well as ensuring adherence to best practice treatment protocols.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 171340 question first answered 11/09/2018 14:23:08 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

969083

	registered interest
	date	06/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of levels of funding on the ability of the NHS to increase access to radiotherapy.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	171339
	answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>Since 2016, the Radiotherapy Modernisation programme has seen £130 million of new funding invested in improving radiotherapy equipment. As a result, the National Health Service has so far received 73 new or upgraded linear accelerators, enabling the delivery of advanced treatment techniques and faster treatment times. From April 2019, NHS England will be establishing 11 Radiotherapy Networks to build on this investment and lead the development of services at a local level. This will include ensuring that every patient benefits from best clinical practice and has access to innovative and advanced treatments and techniques.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 15:02:53 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

969086

	registered interest
	date	06/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how NHS England monitors clinical commissionng groups' cancer treatment performance in respect of access to advanced radiotherapy; and what steps NHS England takes to address instances of poor performance.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	171340
	answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>Clinical commissioning groups are not responsible for ensuring access to advanced radiotherapy techniques, such as Intensity Modulated Radiotherapy (IMRT). The commissioning of all radiotherapy in England is the responsibility of NHS England’s Specialised Commissioning team. Access to IMRT is monitored against a national average access standard of 25%, performance against this standard is consistently around 45%. From April 2019, Radiotherapy Networks, working in close partnership with Specialised Commissioners and Cancer Alliances, will play a key role in increasing access to both advanced and innovative radiotherapy, as well as ensuring adherence to best practice treatment protocols.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170800 question first answered 11/09/2018 14:23:08 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

969472

	registered interest
	date	07/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 January 2018 to Question 147424 on Radiotherapy, when the postcode-level dataset which will enable the calculation of travel times to radiotherapy centres will be published.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	171667
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>In June 2018, The National Cancer Registration and Analysis Service (NCRAS) published three reports relating to patient travel times and cancer, in response to the Independent Cancer Taskforce recommendation 27.</p><p> </p><p>The reports are available at the following link:</p><p> </p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/travel_times" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/travel_times</a></p><p> </p><p>The reports cover the following topics:</p><p>- Travel Times and Methodology summarises NCRAS’ investigations of several possible ways of calculating travel times;</p><p>- Travel Times and Cancer Survival is an overview of survival for the four most common cancers, relative to travel time to the nearest hospital with a relevant multidisciplinary team; and</p><p>- Travel Times and Cancer Treatment is a report on treatment with radiotherapy for localised prostate cancer, relative to travel time to a radiotherapy centre.</p><p> </p><p>Postcode-level data is potentially disclosive and is therefore not made routinely available. Such data may be made available to researchers who apply through Public Health England’s Office for Data Release, with a specific health-care related research question and appropriate research ethics permissions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/09/2018 16:38:09 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

969473

	registered interest
	date	07/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the Government response to the consultation on allocating funds to radiotherapy services which closed on 24 January 2018.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	171668
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>Following the consultation – ‘Modernising radiotherapy services in England’ – NHS England plan to publish a consultation report which outlines the feedback themes, alongside publication of the final radiotherapy service specification. The publication is currently expected to take place in autumn 2018.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 171669 question first answered 12/09/2018 16:39:21 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

969477

	registered interest
	date	07/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the oral contribution of the Parliamentary Under Secretary of State for Health and Social Care of 10 January 2018, Official Report, column 146WH, when he plans to (a) publish the findings of the consultation on making radiotherapy services more accessible and (b) assess data on travel times for such therapy.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	171669
	answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>Following the consultation – ‘Modernising radiotherapy services in England’ – NHS England plan to publish a consultation report which outlines the feedback themes, alongside publication of the final radiotherapy service specification. The publication is currently expected to take place in autumn 2018.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 171668 question first answered 12/09/2018 16:39:21 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

971811

	registered interest
	date	11/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what facilities in the UK offer high-energy proton beam cancer therapy treatment in (a) the NHS and (b) the private sector.
	tabling member constituency	East Worthing and Shoreham
	tabling member printed	Tim Loughton
	uin	173485
	answer	answer is ministerial correction date of answer 09/10/2018 answer text <p>In April 2012, the Secretary of State for Health and Social Care announced that £250 million would be invested to build proton beam therapy facilities at The Christie Hospital in Manchester and University College London Hospital (UCLH). Contracts were signed with Varian Medical Systems, Interserve Construction at The Christie, and Bouygues UK at UCLH at the end of July 2015. The Christie has been operational since 20 August 2018 and expects the first patients to be treated in the autumn. UCLH is currently on schedule to begin treating patients in summer 2020.</p><p> </p><p>NHS England does not hold information about high-energy proton beam provision in the private sector.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/10/2018 16:53:23 answering member 4067 label Biography information for Steve Brine
	tabling member	114 label Biography information for Tim Loughton